期刊
AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 113, 期 5, 页码 1083-1092出版社
OXFORD UNIV PRESS
DOI: 10.1093/ajcn/nqab091
关键词
biomarker; cancer; cardiovascular disease; diabetes; diet assessment; dietary intervention; energy consumption; macronutrient; measurement error; women's health
资金
- National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [HHSN268201100046C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C, HHSN271201600004C]
- National Cancer Institute [R01 CA119171, P30 CA15704]
- NIH [S10 OD021562]
The DM trial and WHI nutritional biomarker studies show that a low-fat dietary pattern intervention can reduce breast cancer mortality, benefit diabetes and coronary artery disease, without observed adverse effects or changes in all-cause mortality. Studies of intake biomarkers suggest important associations of total energy intake and macronutrient dietary composition with major chronic diseases among postmenopausal women.
The dietary modification (DM) clinical trial, within the Women's Health Initiative (WHI). studied a low-fat dietary pattern intervention that included guidance to increase vegetables, fruit, and grains. This study was motivated in part from uncertainty about the reliability of observational studies examining the association between dietary fat and chronic disease risk by using self-reported dietary data. In addition to this large trial, which had breast and colorectal cancer as its primary outcomes, a substantial biomarker research effort was initiated midway in the WHI program to contribute to nutritional epidemiology research more broadly. Here we review and update findings from the DM trial and from the WHI nutritional biomarker studies and examine implications for future nutritional epidemiology research. The WHI included the randomized controlled DM trial (n = 48,835) and a prospective cohort observational (OS) study (n = 93,676), both among postmenopausal US women, aged 50-79 y when enrolled during 1993-1998. Also reviewed is a nutrition and physical activity assessment study in a subset of 450 OS participants (2007-2009) and a related controlled feeding study among 153 WHI participants (2010-2014). Long-term follow-up in the DM trial provides evidence for intervention-related reductions in breast cancer mortality, diabetes requiring insulin, and coronary artery disease in the subset of normotensive healthy women, without observed adverse effects or changes in all-cause mortality. Studies of intake biomarkers, and of biomarker-calibrated intake, suggest important associations of total energy intake and macronutrient dietary composition with the risk for major chronic diseases among postmenopausal women. Collectively these studies argue for a nutrition epidemiology research agenda that includes major efforts in nutritional biomarker development, and in the application of biomarkers combined with self-reported dietary data in disease association analyses. We expect such efforts to yield novel disease association findings and to inform disease prevention approaches for potential testing in dietary intervention trials. This trial was registered at clinicaltrials.gov as NCT00000611.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据